Liver Resection for Colorectal Secondaries by Sugarbaker, Paul H.
HPB Surgery, 1992, Vol. 6, pp. 65-68
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 1992 Harwood Academic Publishers GmbH
Printed in the United Kingdom
HPB INTERNATIONAL
II, _llL III IIII IIIII
EDITORIAL & ABSTRACTING SERVICE JOHN TERBLANCHE, EDITOR
Department of Surgery,
Medical School Observatory 7925
Cape Town South Africa
Telephone: (021) 47-1250 Ext. 2
Telefax (021) 448-6461
LIVER RESECTION FOR COLORECTAL
SECONDARIES
ABSTRACT
Scheele, J., Stangl, R., Altendorf-Hofmann, A. and Gall F.P. (1991) Indicators of
prognosis after hepatic resection for colorectal secondaries. Surgery; 110: 13-29.
From 1960 to 1988, 266 patients underwent resection of colorectal secondaries to the
liver with curative intent. All patients were followed until April 1, 1990, or death,
with a median follow-up time of 52 months. Nine patients with minimal macroscopic
residual disease and 38 patients with all gross tumor removed but positive margins
showed a poor prognosis with a median survival time of 13.3 months, the longest
being 42 months. Of the 219 patients having potentially curative resection, 12
patients died postoperatively (5.5%). Acturiai 5, 10 and 20-year survival for the
remaining 207 patients was 39%, 28%, and 18%, respectively. At April 1, 1990, 77
patients were alive with no evidence of disease for up to 24 years, and 12 patients had
died without recurrence. The following factors were associated with less favorable
crude survival: presence and extent of mesenteric lymph node involvement (p
0.0003), grade III/IV primary tumor (p 0.035), synchronous diagnosis of
metastases (p 0.017), satellite metastases (p 0.0003), limited resection margins
(p 0.019), and nonanatomic procedures (p 0.013). With respect to disease-free
survival, grading of the primary (p 0.055) and the extent of clear margins (p
0.19) failed to achieve statistical significance. Two other criteria are commonly
recommended as absolute contraindications to hepatic resection" extrahepatic dis-
ease and the presence of four or more independent metastases. A radical excision of
all detectable disease may rarely be possible in these circumstances. Nevertheless,
within the curative settings, no significant predictive value regarding either overall
or disease-free survival was found in this series. Three corresponding "high risk"
patients are alive without disease at 5 to 11 years from hepatic resection. These
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patients with more advanced intrahepatic or concomitant limited extrahepatic
disease require a particularly thorough diagnostic work up. As no superior thera-
peutic alternative is currently available, an aggressive surgical approach may
occasionally be justified, and may, in a small portion, result in definite tumor
control. (Surgery 1991; 110: 13-29).
PAPER DISCUSSION
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These authors are to be congratulated on the high quality of their clinical
contribution. They present to us a convincing confirmation of some "Indicators of
prognosis after hepatic resection for colorectal secondaries" that have been pre-
viously described1. They add some information previously unavailable. The value
of a large single institution study becomes clear as this paper is studied. These
authors confirm that positive margins of resection, lymph node invasion present in
the primary tumor, and synchronous versus metachronous diagnosis are important
prognostic features that must be considered in the selection of patients for resection
of liver secondaries.
New information not previously available concerns their work with satellite
metastases. Disease free survival and survival were both significantly diminished in
the presence of satellite lesions (p value 0.003 and 0.0003 respectively).
Apparently, satellite tumor nodules indicate a tumor biology in which the metasta-
tic process is prominent. Local regional metastases in and around the hepatic tumor
indicate that systemic metastases are more likely to occur or that other distant
cancer foci within the liver are more likely to occur.
However, perhaps that most important clinical message from Erlangen concerns
our overall approach to patients with metastatic colorectal cancer. It seems that
large bowel cancer as a metastatic process behaves differently than, for example,
breast malignancy2. Using the terminology of Weiss, et al., colorectal cancer seems
to be relatively more metastatically inefficient than breast cancer3. Is there a single
patient with metastatic breast cancer to lung, liver, or other sites in whom the
surgical removal of this disease led to a long term disease free survival?
Dr Scheele and colleagues lead us to conclude that the number one criteria for
selection of patients for liver resection or liver resection plus resection of extra
hepatic disease is one’s ability to remove all clinically evident disease with a clear
margin. Contradictory to previously accepted general surgical rules, extra hepatic
disease completely resected did not impact adversely on either survival or disease
free survival in this group of 266 patients! Both groups of patients had a projected
10 year survival disease free of approximately 30%. The time to recurrence was
slightly increased in those patients who had liver metastases plus extra hepatic
disease completely resected; but long term follow-up showed that the "surgical
complete response" is associated with a respectable long term disease free survival.
Although these data provided by Dr Scheele and colleagues strongly supports the
use of surgery in patients with hepatic secondaries, these data do not make the
surgeon’s task easier. The surgeon’s skills must provide" (1) Proper patient
selection so that all patients are clinically disease free at the close of an operativeHPB INTERNATIONAL 67
procedure; and (2) Sufficient technical expertise to achieve a negative margin of
excision, prevent excessive intraoperative blood loss, leave the abdomen hemosta-
tically intact and without bile leaks, and preserve sufficient liver parenchyma as
required for an event free postoperative course.
Our studies suggest that the CT portogram may show preoperatively better than
any other radiologic study which patients will be left with a positive margin of
resection on a major vascular structure and which patients can be resected with a
clear margin of normal liver4. Others, have made these judgements intraoperati-
vely through the use of an intraoperative ultrasound. Because the CT portogram
may prevent unnecessary exploratory surgery in some patients, we have preferred
this examination and supplement these findings with intraoperative ultrasound.
Liver surgery as practiced in Erlangen is not for the uninitiated generalist. To
achieve the extensive resections performed by this group with a low (5.5%)
operative mortality requires special expertise. Also, segment oriented resections to
remove multiple metastases and yet preserve parenchyma thereby assuring a
smooth postoperative course are technically demanding. Especially those segmen-
tal resections that remove liver segments above the transverse plane of the liver
(segments, 4A, 8, and 7) should not be attempted without special training and
experience as a liver resectionist.
Especially timely is the data presented concerning follow-up surgery. Thirty-four
patients with initially curative liver resections underwent reoperation for cancer
relapse with curative intent. Eighteen of these patients were again surgical
complete responses. At the time of publication, seven of these 18 patients remain
alive with no evidence of disease. Again, this information increases rather then
relieves the surgeon’s burden for giving care to patients with cancer. This means
that careful follow-up of patients who have had resection of liver secondaries is
required because approximately 10% will recur with resectable disease. This makes
them a candidate for further surgery and approximately one quarter of these
patients can be salvaged by repeat resections of metastatic disease!
One may ask where does this surgical approach to the treatment of metastatic
disease lead us. Can surgery interrupt the cascade phenomenon and change the
natural history of a stepwise process into a curable local-regional process? Is there a
window-of-time through which surgery can salvage a proportion of large bowel
cancer patients from otherwise inevitable death from cancer? What are the
implications of these hypotheses for the overall management of colorectal cancer
patients? There are physician costs, patient costs, and quality of life implications
that must be addressed. Yet, even in our current state of ignorance, I am convinced
that the surgical complete response in properly selected patients is durable (ideally
100%) and that it results in cure in 1/2 of these patients. I feel compelled to continue
to offer liver resection or liver resection plus the complete removal of extra hepatic
disease to patients who can be made clinically disease free.
Pursuit of a surgical complete response may be a much more reasonable
treatment alternative than systemic chemotherapy. Unfortunately, at the present
time a majority of patients with liver metastases go straight to chemotherapy
treatments and the more promising treatment strategy, surgery for metastatic
disease, is ignored until chemotherapy can no longer be employed because of
disease progression or drug toxicity. My personal impression is that this unnecess-
ary delay closes the window of surgical opportunity for many patients.
What is needed is groups of people who work together to determine if complete68 HPB INTERNATIONAL
responses with surgery combined with modern chemotherapy in a prospective study
will improve the long term survival of these patients treatments. Scheele and
colleagues must be congratulated in that they have shown the benefits of a surgical
complete response in continued efforts to optimize the surgical care of patients with
colorectal cancer. They have also contributed to our fund of knowledge concerning
this disease process.
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